THREE VACCINES FOR BIODEFENSE

Release Date:  June 13, 2002

NOTICE:  NOT-AI-02-028

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov)

Receipt Date for Letters of Interest: July 12, 2002

The National Institute of Allergy and Infectious Diseases (NIAID) is interested 
in expediting the completion of development of three vaccines for biodefense:  
(1) Rift Valley Fever vaccine; (2) Plague vaccine; and, (3) Smallpox vaccine for 
persons at high-risk of complications from currently available vaccines (e.g., 
the immune deficient).

NIAID is interested in receiving letters of interest regarding these vaccines 
from organizations that have candidate vaccines under clinical development. 
Interested organizations should submit a letter of interest that contains a 
detailed description of the product and summary results of pre-clinical and 
early clinical testing. The letter of interest along with any supporting 
documentation shall not exceed 10 pages.  Letters of interest will be kept 
confidential and will help in determining the need for an RFP to support further
development, testing, and licensure of these products, and in assembling a 
potential source list for distribution if an RFP is issued.

INQUIRIES

Submit your response to the address listed below:

Barbara A. Shadrick
Senior Contracting Officer
Contract Management Branch, DEA
National Institute of Allergy and Infectious Diseases, NIH
6700-B Rockledge Drive, Room 2230, MSC 7612
Bethesda, MD  20892-7612 
Phone:  301-496-7288
Fax:  301-480-5253 or 301-402-0972
E-Mail:  bs92y@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.